Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLN-4601 in Recurrent Glioblastoma Multiforme
NCT00730262Phase 2Terminated
- Sponsor
- Thallion Pharmaceuticals Inc.
- Start
- Aug 2008
- Primary completion
- Apr 2010
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
A Phase 2 trial of diazepinomicin in glioblastoma multiforme (GBM), sponsored by Thallion Pharmaceuticals Inc.. Started Aug 2008; status: terminated.
02
Drugs
diazepinomicin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00730262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730262.